| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.26 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |